Do infants born at 34 weeks gestation (late preterm) have an increased risk of cognitive problems during childhood and adulthood?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 4, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Late Preterm Infants Born at 34 Weeks: Cognitive Outcomes

Yes, infants born at 34 weeks gestational age (late preterm) do have an increased risk of cognitive problems during childhood, though the evidence suggests these risks are generally mild and may be less pronounced than in infants born earlier than 34 weeks.

Key Evidence from Guidelines

The most authoritative guidance comes from the 2012 American Heart Association scientific statement, which explicitly addresses this population. Healthy late-preterm infants (34-36 weeks) compared with healthy term infants (≥37 weeks) had a greater risk for developmental delay and school-related problems through the first 5 years of life 1. This guideline recommends heightened developmental screening and evaluation for late-preterm infants born at 34-36 weeks' gestation 1.

Specific Cognitive Domains Affected

Based on recent high-quality research, the cognitive challenges in late preterm infants include:

Childhood (School Age)

  • Executive function deficits: Problems with attention, planning, and cognitive flexibility 2, 3
  • Short-term verbal memory impairments 2
  • Processing speed delays 3
  • Attention problems: 65% showed abnormal scores on ADHD diagnostic measures in one cohort 3
  • Borderline intelligence functioning: 24-32% scored in the borderline range (IQ 70-85) 3
  • Academic difficulties: Higher risk for literacy skills problems and poor school performance 2

Important Nuance: The 34-Week Threshold

The most recent and highest quality study (2025) provides critical clarification: Among 5,946 children aged 9-10 years, those born at 34-36 weeks (late preterm) performed similarly to full-term peers on comprehensive cognitive testing 4. However, children born at 32-33 weeks (moderately preterm) showed significant deficits across multiple domains including vocabulary, working memory, and episodic memory 4.

This suggests that 34 weeks may represent a developmental threshold, with infants born at exactly 34 weeks potentially having better outcomes than those born at 32-33 weeks.

Adulthood Outcomes

The evidence for long-term adult outcomes is more reassuring:

  • A 2018 study of young adults (mean age 25 years) found that late-preterm birth per se did not significantly increase risk of poorer neurocognitive functioning in adulthood after adjustments 5
  • However, the combination of late preterm birth AND being small for gestational age (SGA) did result in persistent deficits, with Full-scale IQ scores 9-12 points lower than term-born peers 5

Critical Risk Modifiers

The cognitive outcomes are significantly influenced by:

  1. Birth weight for gestational age: Late preterm infants who are also SGA face substantially higher risks 5
  2. Neonatal complications: The presence of respiratory problems, infections, or other morbidities amplifies risk 6
  3. Socioeconomic factors: Maternal social disadvantage compounds cognitive risks 7

Clinical Recommendations

Based on the guideline evidence, implement the following screening protocol:

  • Developmental screening at: 9,18,30, and 48 months of age (per AAP guidelines referenced in the AHA statement) 1
  • Autism screening: At 18 and 24 months 1
  • Periodic reevaluation: At 12-24 months, 3-5 years, and 11-12 years of age 1
  • Early intervention referral: If delays are identified before age 5 or kindergarten entry 1

Common Pitfalls to Avoid

  1. Don't assume all late preterm infants have the same risk: Those born at exactly 34 weeks appear to have better outcomes than those born at 32-33 weeks 4
  2. Don't overlook the "double burden": Late preterm birth combined with SGA status creates substantially higher risk 5
  3. Don't dismiss transient early delays: Some difficulties resolve, but others persist and affect academic achievement 2
  4. Don't delay screening: Problems may not become apparent until school entry when cognitive demands increase 6

Bottom Line

While late preterm infants born at 34 weeks face increased risk for mild cognitive difficulties during childhood—particularly in executive function, attention, and processing speed—many of these challenges may improve over time. The key is systematic developmental surveillance and early intervention when problems are identified, as recommended by the AHA guidelines 1. Infants born at exactly 34 weeks appear to fare better than those born earlier, and most will not have severe long-term impairments, especially if they are appropriate weight for gestational age and without significant neonatal complications.

Related Questions

In a 46-year-old woman presenting to the emergency department with severe right upper quadrant abdominal pain, fever, scleral icterus, and elevated alkaline phosphatase and bilirubin, what is the most likely diagnosis?
What is the comprehensive protocol for performing a lower‑extremity arterial Doppler ultrasound in an adult patient?
How should a 2-year-old child presenting with a dry cough and wheezing be managed?
In an 82-year-old patient with cyanotic lips despite a pulse‑oximeter reading of 100%, what is the appropriate immediate management?
What are the indications, contraindications, and procedural steps for performing a bone marrow aspiration?
How effective is Metamucil (psyllium husk) for managing irritable bowel syndrome, especially constipation-predominant IBS?
Is clobetasol 0.05% appropriate for treating an extensive poison‑ivy rash in an adult, and how should it be applied?
What oral antibiotic regimen is recommended for treating deep tissue infection or bone osteomyelitis, including coverage for MSSA, MRSA, streptococci, Gram‑negative and anaerobic organisms?
What are the differences between Rexulti (brexpiprazole) and Auvelity (dextromethorphan‑bupropion) in the treatment of dementia?
Can a patient with a positive antinuclear antibody (ANA) and a positive ANA titer but a negative anti‑double‑stranded DNA (dsDNA) test still not have an autoimmune disorder?
In a patient with NSTEMI who took 5 mg apixaban (Eliquis) this morning, should I start an unfractionated heparin infusion?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.